ADVFN US – Market Content Editor
-

Krispy Kreme Shares Climb 7% as Turnaround Strategy Gains Early Traction
Shares of Krispy Kreme, Inc. (NASDAQ:DNUT) jumped 7.43% in premarket trading on Thursday after the company posted better-than-expected third-quarter earnings, signaling that its turnaround plan is beginning to take hold. The doughnut maker reported adjusted earnings of $0.01 per share, easily beating Wall Street’s forecast for a $0.06 loss. While revenue came in slightly below…
-

SharkNinja Shares Jump 11% After Blowing Past Q3 Estimates
Shares of SharkNinja, Inc. (NYSE:SN) surged 11.07% in premarket trading on Thursday after the company delivered third-quarter results that handily beat Wall Street expectations, powered by strong performance across all major product categories. The global product design and technology company posted adjusted earnings of $1.50 per share, a massive $0.62 above the analyst consensus of…
-

Ascent Solar Shares Climb After Partnership with CisLunar Industries
Shares of Ascent Solar Technologies Inc. (NASDAQ:ASTI) rose 5% in premarket trading on Thursday after the company announced a teaming agreement with CisLunar Industries to co-develop next-generation power systems for space missions. Under the collaboration, the two Colorado-based firms will integrate Ascent’s thin-film photovoltaic technology with CisLunar’s high-efficiency power conversion systems to produce durable, energy-efficient…
-

Ducommun Shares Edge Higher as Q3 Earnings Beat Expectations and Defense Momentum Persists
Ducommun Inc. (NYSE:DCO) reported third-quarter results on Thursday that surpassed analyst forecasts, supported by another strong performance in its defense segment even as commercial aerospace activity remained under pressure. The company’s stock climbed 2.12% in premarket trading following the release. The aerospace and defense manufacturer posted adjusted earnings of $0.99 per share, topping the consensus…
-

Prestige Consumer Healthcare Beats Q2 Expectations and Raises EPS Guidance
Prestige Consumer Healthcare Inc. (NYSE:PBH) reported fiscal second-quarter 2026 results on Thursday that topped analyst estimates, as earnings outperformed expectations despite lingering supply challenges in its eye care division. The healthcare products maker posted adjusted earnings per share of $1.07, exceeding the consensus estimate of $0.97. Revenue came in at $274.1 million, above expectations of…
-

Haemonetics Shares Gain After Q2 Beat and Upgraded Full-Year Outlook
Haemonetics Corporation (NYSE:HAE) shares climbed 3% in premarket trading Thursday after the medical technology company posted strong fiscal second-quarter results that topped Wall Street expectations and prompted an upgrade to its full-year guidance. For the quarter ended September 27, Haemonetics reported adjusted earnings of $1.27 per share, beating the analyst consensus of $1.11. Revenue came…
-

YETI Lifts Profit Outlook After Q3 Earnings Beat, Narrows Sales Guidance
YETI Holdings (NYSE:YETI) raised its full-year earnings forecast on Thursday after reporting third-quarter results that topped analyst expectations, supported by continued strength in its Coolers & Equipment segment despite softer Drinkware sales. The company posted earnings per share of $0.61, ahead of the $0.58 consensus estimate, while revenue grew 2% year over year to $487.8…
-

Titan International Rises as Q3 Results Beat Expectations on Strong Segment Growth
Titan International, Inc. (NYSE:TWI) shares edged 1.9% higher in premarket trading Thursday after the off-highway wheel and tire manufacturer posted third-quarter earnings and revenue that surpassed analyst forecasts, supported by solid performance across its agriculture and earthmoving/construction divisions. The company reported adjusted earnings of $0.04 per share, topping Wall Street’s estimate of a $0.03 loss.…
-

ACI Worldwide Beats Q3 Forecasts and Lifts Full-Year Outlook on Broad-Based Growth
ACI Worldwide (NASDAQ:ACIW) shares advanced Thursday after the global payments software company reported third-quarter results that surpassed Wall Street expectations and prompted an upward revision to its full-year guidance. The firm posted earnings of $0.88 per share, topping analyst projections of $0.68, while revenue climbed 7% year over year to $482.36 million, above the consensus…
-

BeOne Medicines Rises After Strong Q3 Beat Driven by BRUKINSA Sales
BeOne Medicines Ltd. (NASDAQ:ONC) shares gained 0.8% in premarket trading Thursday after the global oncology company posted third-quarter results that topped Wall Street expectations, powered by surging sales of its leading cancer therapy BRUKINSA. The company reported adjusted earnings of $2.65 per American Depositary Share (ADS), far exceeding the analyst consensus of $0.80. Revenue totaled…